Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

November 16, 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

September 28, 2019

Protracted Opioid Use Not Uncommon After Cardiothoracic Surgery

News Daily News

Protracted Opioid Use Not Uncommon After Cardiothoracic Surgery

August 23, 2019

Conversations in Cardiology: The Push for High-Sensitivity Troponin

News Opinion Conversations in Cardiology

Conversations in Cardiology: The Push for High-Sensitivity Troponin

August 02, 2019

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

News Daily News

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Marcus A. Banks

July 24, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

Atypical pneumonia....Very Atypical!

Presentation ECHO/IMAGING 2019

Atypical pneumonia....Very Atypical!

Presenter: Gerard P. Aurigemma

March 22, 2019

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

March 13, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.